The second most populous country in the world India, has emerged as a major vaccine producer in recent years, focusing efforts on geographical regions where vaccines are not funded by the United Nations or charitable organizations, reports The Pharma Letter’s India correspondent.
Though the country is attracting funds from entities like the Bill and Melinda Gates Foundation and GAVI, a global vaccine alliance, the recently unveiled National Biotechnology Development Strategy, aims to ensure that India will start making its own supply of vaccines and antibiotics, which will benefit the country's economy.
The Indian government's current budget for immunization is around $89.25 million, though sources indicated the immunization spend is likely to shoot up to $267 million by 2017.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze